Current:Home > StocksWegovy patients saw 20% reduction in cardiovascular risks, drugmaker says-InfoLens
Wegovy patients saw 20% reduction in cardiovascular risks, drugmaker says
View Date:2024-12-23 21:26:52
Wegovy, one of a new class of drugs used for weight loss, reduced the risk of heart attacks in overweight adults in a large trial, according to its manufacturer.
Drugmaker Novo Nordisk on Tuesday reported the results of a new study that tracked more than 17,000 adults over the age of 45 who were overweight or obese and had cardiovascular disease but no history of diabetes.
The trial showed that once-weekly Wegovy injections cut the likelihood of serious cardiac events such as heart attacks, strokes and cardiovascular deaths among the study's participants by 20%. That represents a better result than analysts had expected, and the findings could make a strong case for insurers to cover the costly weight-loss drug, Reuters reported.
"The results could improve the willingness to pay for obesity drugs and provide higher incentive to treat obesity at earlier state," noted Henrik Hallengreen Laustsen, an analyst at Jyske Bank, speaking to Reuters.
The trial demonstrates that the medication "has the potential to change how obesity is regarded and treated," Martin Holst Lange, executive vice president for Development at Novo Nordisk, said in a statement.
Wegovy clinical trials
Wegovy, a brand-name formulation of the GLP-1 receptor agonist semaglutide, received approval to treat adult obesity in 2021. An early study showed that patients taking semaglutide lost 15% of their body weight in 68 weeks.
This latest study shows semaglutide can reduce patients' risks of experiencing cardiac events, which are more common in overweight and obese individuals. Obese adults are 28% more likely to develop heart disease compared with adults with a healthy body-mass index, even when they lack other risk factors, a 2018 study showed.
How much is Wegovy?
Even so, some insurers aren't rushing to cover semaglutide.
Wegovy can cost $1,350 per month, according to telehealth and prescription coupon website GoodRx. That's hundreds of dollars more than more traditional weight-loss medications like Orlistat.
Some insurers are paying tens of millions of dollars per month for semaglutide as more Americans are prescribed the medications, the Wall Street Journal reported.
- Ozempic, Mounjaro manufacturers sued over claims of "stomach paralysis" side effects
- Ozempic side effects could lead to hospitalization
- Woman sues drug makers of Ozempic and Mounjaro
That's led some employers, like the University of Texas System, to end coverage of Wegovy for individuals covered by their health plans, according to the Journal. Other employers are implementing coverage restrictions to deal with the medications' rising costs.
Semaglutide safety concerns
Public concerns about the safety of the drug may also be an obstacle to its wider adoption as a first-line treatment against obesity. Patients who have taken Wegovy and other semaglutide-based medications have experienced unpleasant, and sometimes dangerous, side effects, like chronic abdominal pain and hypoglycemia.
Earlier this month, a personal injury law firm filed a lawsuit against the manufacturers of Ozempic, Wegovy and Mounjaro, alleging the drugmakers failed to warn patients the treatments could cause gastroparesis, a painful condition in which food is slow to move through the stomach.
- In:
- Weight Loss
veryGood! (811)
Related
- Queen Elizabeth II's Final 5-Word Diary Entry Revealed
- 11 Hidden Sales You Don't Want to Miss: Pottery Barn, Ulta, SKIMS & More
- Train crash in eastern Pakistan injures at least 30. Authorities suspend 4 for negligence
- Crashed F-35: What to know about the high-tech jet that often doesn't work correctly
- Nelly will not face charges after St. Louis casino arrest for drug possession
- Brewers clinch playoff berth, close in on NL Central title after routing Marlins
- After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
- How North Carolina farmers are selling their grapes for more than a dollar per grape
- 'Squid Game' creator lost '8 or 9' teeth making Season 1, explains Season 2 twist
- 2 dead, 2 hurt following early morning shooting at Oahu boat harbor
Ranking
- Full House Star Dave Coulier Shares Stage 3 Non-Hodgkin's Lymphoma Diagnosis
- One Kosovo police officer killed and another wounded in an attack in the north, raising tensions
- UNGA Briefing: There’s one more day to go after a break — but first, here’s what you missed
- Vaccines are still tested with horseshoe crab blood. The industry is finally changing
- Skai Jackson announces pregnancy with first child: 'My heart is so full!'
- Stop What You're Doing: Kate Spade's Surprise Sale Is Back With 70% Off Handbags, Totes and More
- National Cathedral unveils racial justice-themed windows, replacing Confederate ones
- Risk factor for Parkinson's discovered in genes from people of African descent
Recommendation
-
5-year-old boy who went missing while parent was napping is found dead near Oregon home, officials say
-
New Jersey house explosion hospitalizes 5 people, police say
-
New York City further tightens time limit for migrants to move out of shelters
-
Auto workers still have room to expand their strike against car makers. But they also face risks
-
American Idol’s Triston Harper, 16, Expecting a Baby With Wife Paris Reed
-
11 Hidden Sales You Don't Want to Miss: Pottery Barn, Ulta, SKIMS & More
-
Salt water wedge in the Mississippi River threatens drinking water in Louisiana
-
A black market, a currency crisis, and a tango competition in Argentina